In this provocative volume, Shorter offers a revealing account of why psychiatry is "losing ground" in the struggle to treat depression. The book looks at such culprits as the pharmaceutical industry, which is not inclined to market drugs once the patent expires, leading to the endless introduction of new--but not necessarily better--drugs. But the heart of the book focuses on an unexpected villain: the FDA, the very agency charged with ensuring drug safety and effectiveness.
Read More
In this provocative volume, Shorter offers a revealing account of why psychiatry is "losing ground" in the struggle to treat depression. The book looks at such culprits as the pharmaceutical industry, which is not inclined to market drugs once the patent expires, leading to the endless introduction of new--but not necessarily better--drugs. But the heart of the book focuses on an unexpected villain: the FDA, the very agency charged with ensuring drug safety and effectiveness.
Read Less
